Case-by-case combination of the prostate imaging reporting and data system version 2.1 with the Likert score to reduce the false-positives of prostate MRI: a proof-of-concept study
Abdominal Radiology · 2024
DOI: 10.1007/s00261-024-04506-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Abdominal Radiology, 2024. Verfasst von Rossano Girometti und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Radiology, Department of Medicine (DMED), University of Udine, University Hospital S. Maria della Misericordia - Azienda Sanitaria-Unive…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Magnetic Resonance Imaging. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Udine.
Abstract (Originalsprache)
Objectives
To retrospectively investigate whether a case-by-case combination of the Prostate Imaging Reporting and Data System version 2.1 (PI-RADS) with the Likert score improves the diagnostic performance of mpMRI for clinically significant prostate cancer (csPCa), especially by reducing false-positives.
Methods
One hundred men received mpMRI between January 2020 and April 2021, followed by prostate biopsy. Reader 1 (R1) and reader 2 (R2) (experience of > 3000 and < 200 mpMRI readings) independently reviewed mpMRIs with the PI-RADS version 2.1. After unveiling clinical information, they were free to add (or not) a Likert score to upgrade or downgrade or reinforce the level of suspicion of the PI-RADS category attributed to the index lesion or, rather, identify a new index lesion. We calculated sensitivity, specificity, and predictive values of R1/R2 in detecting csPCa when biopsying PI-RADS ≥ 3 index-lesions (strategy 1) versus PI-RADS ≥ 3 or Likert ≥ 3 index-lesions (strategy 2), with decision curve analysis to assess the net benefit. In strategy 2, the Likert score was considered dominant in determining biopsy decisions. Results csPCa prevalence was 38%. R1/R2 used combined PI-RADS and Likert categorization in 28%/18% of examinations relying mainly on clinical features such as prostate specific antigen level and digital rectal examination than imaging findings. The specificity/positive predictive values were 66.1/63.1% for R1 (95%CI 52.9–77.6/54.5–70.9) and 50.0/51.6% (95%CI 37.0-63.0/35.5-72.4%) for R2 in the case of PI-RADS-based readings, and 74.2/69.2% for R1 (95%CI 61.5–84.5/59.4–77.5%) and 56.6/54.2% (95%CI 43.3-69.0/37.1-76.6%) for R2 in the case of combined PI-RADS/Likert readings. Sensitivity/negative predictive values were unaffected. Strategy 2 achieved greater net benefit as a trigger of biopsy for R1 only.
Conclusion
Case-by-case combination of the PI-RADS version 2.1 with Likert score translated into a mild but measurable impact in reducing the false-positives of PI-RADS categorization, though greater net benefit in reducing unnecessary biopsies was found in the experienced reader only. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Radiology, Department of Medicine (DMED), University of Udine, University Hospital S. Maria della Misericordia - Azienda Sanitaria-Universitaria Friuli Centrale (ASU FC), p.le S. Maria della Misericordia, 1…
- UOC Radiologia, Ospedale Civile SS. Giovanni e Paolo, ULSS 3 Serenissima, 6776 - 30122, Castello, Venezia, Italy.
- Division of Medical Statistics, Department of Medicine (DMED), University of Udine, pl.le Kolbe, 4 - 33100, Udine, Italy.
- Pathology Unit, University Hospital S. Maria della Misericordia - Azienda Sanitaria-Universitaria Friuli Centrale (ASU FC), p.le S. Maria della Misericordia, 15 - 33100, Udine, Italy.
- Urology Unit, University Hospital S. Maria della Misericordia - Azienda Sanitaria-Universitaria Friuli Centrale (ASU FC), p.le S. Maria della Misericordia, 15 - 33100, Udine, Italy.
ORCID-Profile: Rossano Girometti
Förderung
- Università degli Studi di Udine
Zitieren
APA
Girometti, R., Peruzzi, V., Polizzi, P., De Martino, M., Cereser, L., Casarotto, L., Pizzolitto, S., Isola, M., Crestani, A., Giannarini, G., & Zuiani, C. (2024). Case-by-case combination of the prostate imaging reporting and data system version 2.1 with the Likert score to reduce the false-positives of prostate MRI: a proof-of-concept study. Abdominal Radiology. https://doi.org/10.1007/s00261-024-04506-2
Vancouver
Girometti R, Peruzzi V, Polizzi P, De Martino M, Cereser L, Casarotto L, et al. Case-by-case combination of the prostate imaging reporting and data system version 2.1 with the Likert score to reduce the false-positives of prostate MRI: a proof-of-concept study. Abdominal Radiology. 2024. doi:10.1007/s00261-024-04506-2
BibTeX
@article{Girometti2024,
author = {Girometti, Rossano and Peruzzi, Valeria and Polizzi, Paolo and De Martino, Maria and Cereser, Lorenzo and Casarotto, Letizia and Pizzolitto, Stefano and Isola, Miriam and Crestani, Alessandro and Giannarini, Gianluca and Zuiani, Chiara},
title = {Case-by-case combination of the prostate imaging reporting and data system version 2.1 with the Likert score to reduce the false-positives of prostate MRI: a proof-of-concept study},
journal = {Abdominal Radiology},
year = {2024},
doi = {10.1007/s00261-024-04506-2}
}
EUVIMED